Bank of Montreal
ACET icon

Bank of Montreal’s Adicet Bio ACET Stock Holding History

Bank of Montreal’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,919
Closed -$113K – 3497
2024
Q3 		$113K Buy
4,919
+4,137
+529% +$92.6K ﹤0.01% 3210
2024
Q2 		$18.5K Buy
+782
New +$21K ﹤0.01% 3589
2021
Q2 		– Sell
-57
Closed -$12K – 3628
2021
Q1 		$12K Hold
57
– – ﹤0.01% 4259
2020
Q4 		$13K Buy
+57
New +$11.7K ﹤0.01% 4584
2020
Q1 		– Sell
-21
Closed -$3K – 4043
2019
Q4 		$3K Sell
21
-1
-5% -$506 ﹤0.01% 4744
2019
Q3 		$22K Buy
22
+10
+83% +$11.2K ﹤0.01% 4031
2019
Q2 		$14K Buy
12
+3
+33% +$2.72K ﹤0.01% 4359
2019
Q1 		$6K Buy
9
+8
+800% +$7.27K ﹤0.01% 3983
2018
Q4 		$1K Buy
+1
New +$1.32K ﹤0.01% 4497
2018
Q3 		– Hold
0
– – – 4474
2018
Q2 		– Hold
0
– – – 4694

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Bank of Montreal's ACET Position: Q4 2024 in Review

Bank of Montreal sold out of Adicet Bio (ACET) in Q4 2024, closing a stake of 4,919 shares — an estimated $113K sold.

Bank of Montreal first reported a position in ACET in Q4 2018 and held it in 9 quarters. The position peaked at $113K in Q3 2024. 64 funds tracked by Wall St. Rank hold ACET as of Q4 2024.

  • Bank of Montreal reported no remaining Adicet Bio position as of Q4 2024 after selling out during the quarter.
  • Bank of Montreal sold 4,919 Adicet Bio shares in Q4 2024, an estimated $113K.
  • Bank of Montreal first reported a position in Adicet Bio in Q4 2018 and held it in 9 quarters.
  • Bank of Montreal's Adicet Bio position peaked at $113K in Q3 2024.
  • 64 funds tracked by Wall St. Rank held Adicet Bio as of Q4 2024.

Based on Bank of Montreal's 13F filing for Q4 2024, filed 13 Feb 2025.